This report provides exclusive insights into the COVID-19 impact on the Bisphosphonates Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Bisphosphonates Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Bisphosphonates Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
bisphosphonates market provides an in-depth analysis of segments and sub-segments
in the global as well as regional bisphosphonates market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional bisphosphonates market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast and dollar
values of global bisphosphonates market. According to the report, the global
bisphosphonates market is projected to grow at a CAGR of 5.9% over the forecast
period of 2019-2025.
The key players in the bisphosphonates market are Merck & Co.,
Inc., Sanofi-Aventis, F. Hoffmann-La Roche Ltd., Novartis International AG,
Procter & Gamble Company, Pfizer Inc., Teva Pharmaceuticals Industries
Ltd., Apotex Inc., Cobalt Pharmaceuticals Inc., Genentech Inc., and other
companies. The companies are adopting strategies such as mergers, acquisitions,
and new product launches to maximize their market share.
The growing geriatric population drives the growth of the
bisphosphonates market. The increasing number of women in the post-menopausal
stage stimulates the growth of the bisphosphonates market. A post-menopausal
woman loses bone density and suffers from the weakening of bone. Aged people
get fractures due to a decrease in bone density and weakening of bones. The
increasing prevalence of bone diseases contributes to the growth of the
bisphosphonates market. There is a rise in the number of patients suffering
from osteoporosis. In 2017, as per International Osteoporosis Foundation,
around 200 million people worldwide suffered from osteoporosis. Bisphosphonates
are beneficial to prevent bone damage and strengthen and hardens bones.
Bisphosphonates are widely used to cure bone-related diseases such as
osteoporosis, bone metastasis, and myeloma. Bisphosphonates are also useful to
cure patients suffering from breast cancer and prostate cancer. On the other
side, side effects of bisphosphonates like incapacitating bone, joint and
musculoskeletal pain restrain the growth of bisphosphonates market. Moreover,
research brings novel uses and benefits of bisphosphonates that creates novel
opportunities for the bisphosphonates market.
Geographically, North America is expected to hold a dominant share
in the global bisphosphonates market. The rising healthcare spending in the USA
drives the growth of North America's bisphosphonates market. The increasing
prevalence of myeloma in Europe contributes to the growth of the
bisphosphonates market in Europe. Asia-Pacific region is anticipated to grow in
the global bisphosphonates market with a healthy CAGR over the forecast period.
The growing number of cases of osteoporosis and rising geriatric population
stimulate the growth of the Asia-Pacific bisphosphonates market.
The report on global bisphosphonates market covers segments such
as therapeutic areas, application, distribution channel, and mode of delivery.
On the basis of therapeutic areas, the sub-markets include cancer, and
degenerative bone diseases. On the basis of application, the sub-markets
include orthopedics, oncology, and gynecology. On the basis of the distribution
channel, the sub-markets include hospitals, online channels, and retail
pharmacies. On the basis of mode of delivery, the sub-markets include oral, and
The report provides profiles of the companies in the market such
as Merck & Co., Inc., Sanofi-Aventis, F. Hoffmann-La Roche Ltd., Novartis
International AG, Procter & Gamble Company, Pfizer Inc., Teva
Pharmaceuticals Industries Ltd., Apotex Inc., Cobalt Pharmaceuticals Inc.,
Genentech Inc., and other companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of bisphosphonates
market. Moreover, the study highlights current market trends and provides
forecast from 2019-2025. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.